Turning Point Therapeutics, Inc.
TPTX · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $1,948,248 | $4,976,815 | $1,502,742 | $431,710 |
| - Cash | $427,879 | $554,101 | $48,188 | $101,029 |
| + Debt | $5,579 | $3,819 | $5,055 | $0 |
| Enterprise Value | $1,525,948 | $4,426,533 | $1,459,609 | $330,681 |
| Revenue | $30,829 | $25,000 | $0 | $0 |
| % Growth | 23.3% | – | – | – |
| Gross Profit | $30,829 | $0 | $0 | $0 |
| % Margin | 100% | 0% | – | – |
| EBITDA | -$232,584 | -$154,899 | -$70,552 | -$24,646 |
| % Margin | -754.4% | -619.6% | – | – |
| Net Income | -$236,551 | -$157,292 | -$72,131 | -$24,785 |
| % Margin | -767.3% | -629.2% | – | – |
| EPS Diluted | -5.79 | -3.85 | -2.99 | -1.66 |
| % Growth | -50.4% | -28.8% | -80.1% | – |
| Operating Cash Flow | -$153,885 | -$82,793 | -$57,757 | -$23,533 |
| Capital Expenditures | -$2,427 | -$1,264 | -$1,744 | -$302 |
| Free Cash Flow | -$156,312 | -$84,057 | -$59,501 | -$23,835 |